Fatal leukemia in interleukin-15 transgenic mice

Blood Cells, Molecules, and Diseases

Volumn 27, Issue 1, 2001, Pages 223-230

  Fehniger, Todd A ^a,b   Suzuki, Kazuhiro ^a,c   VanDeusen, Jeffrey B ^a,b   Cooper, Megan A ^a,b   Freud, Aharon G ^a   Caligiuri, Michael A ^a,b  

^a OHIO STATE UNIVERSITY   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c GUNMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GROWTH FACTOR; INTERLEUKIN 15;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; GENE OVEREXPRESSION; GENETIC ENGINEERING; HOMEOSTASIS; LEUKEMIA; LEUKEMOGENESIS; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSGENIC MOUSE;

MURINAE; MUS MUSCULUS;

EID: 0035046525     PISSN: 10799796     EISSN: None     Source Type: Journal    
DOI: 10.1006/bcmd.2001.0379     Document Type: Article

References (37)

1. At the cross-roads of inflammation and tumorigenesis
2. A proinflammatory cytokine inhibits p53 tumor suppressor activity
3. Interleukin-1 polymorphisms associated with increased risk of gastric cancer
4. Molecular biology of leukemia
5. Interleukin 15: Biology and relevance to human disease
6. Cloning of a T cell growth factor that interacts with the beta chain of the interleukin-2 receptor
7. Utilization of the beta and gamma chains of the IL-2 receptor by the novel cytokine IL-15
8. Identification and cloning of a novel IL-15 binding protein that is structurally related to the alpha chain of the IL-2 receptor
9. The interleukin (IL) 2 receptor beta chain is shared by IL-2 and a cytokine, provisionally designated IL-T, that stimulates T-cell proliferation and the induction of lymphokine-activated killer cells
10. Interleukin (IL) 15 is a novel cytokine that activates human natural killer cells via components of the IL-2 receptor
11. + hematopoietic progenitor cells
12. A potential role for interleukin-15 in the regulation of human natural killer cell survival
13. Requirement for IRF-1 in the microenvironment supporting development of natural killer cells
14. The transcription factor interferon regulatory factor 1 (IRF-1) is important during the maturation of natural killer 1.1+ T cell receptor-alpha/beta+ (NK1+ T) cells, natural killer cells, and intestinal intraepithelial T cells
15. IL-15 receptor maintains lymphoid homeostasis by supporting lymphocyte homing and proliferation
16. Reversible defects in natural killer and memory CD8 T cell lineages in IL-15 deficient mice
17. Potent and selective stimulation of memory-phenotype CD8+ T cells in vivo by IL-15
18. Development and function of T cells in mice rendered interleukin-2 deficient by gene targeting
19. Immune responses in interleukin-2-deficient mice
20. Interleukin-2 receptor alpha chain regulates the size and content of the peripheral lymphoid compartment
21. The pleiotropic functions of interleukin 15: Not so interleukin 2-like after all
22. Interleukin (IL) 15/IL-T production by the adult T-cell leukemia cell line HuT-102 is associated with a human T-cell lymphotrophic virus type I region/IL-15 fusion message that lacks many upstream AUGs that normally attenuates IL-15 mRNA translation
23. Regulation of IL-15 secretion via the leader peptide of two IL-15 isoforms
24. Generation of secretable and non-secretable interleukin 15 isoforms through alternate usage of signal peptides
25. The 5′ untranslated region, signal peptide, and the coding sequence of the carboxyl terminus of IL-15 participate in its multifaceted translational control
26. Fatal leukemia in interleukin-15 transgenic mice follows early expansions in NK and CD8+ memory-phenotype T cells
27. Studies evaluating the antitumor activity and toxicity of interleukin-15, a new T cell growth factor: Comparison with interleukin-2
28. Control of homeostasis of CD8+ memory T cells by opposing cytokines
29. Aggressive cutaneous NK and NK-like T-cell lymphomas: Clinicopathologic, immunohistochemical, and molecular analyses of 12 cases
30. Flt3 ligand promotes the generation of a distinct CD34(+) human natural killer cell progenitor that responds to interleukin-15
31. Generation of lytic natural killer 1.1+, Ly-49- cells from multipotential murine bone marrow progenitors in a stroma-free culture: Definition of cytokine requirements and developmental intermediates
32. Large granular lymphocytosis
33. Interleukin-15 protects from lethal apoptosis in vivo
34. Aggressive natural killer-like T-cell malignancy with leukemic presentation following solid organ transplantation
35. Interleukin-15 triggers the proliferation and cytotoxicity of granular lymphocytes in patients with lymphoproliferative disease of granular lymphocytes
36. Regulated expression of a murine class I gene in transgenic mice
37. Interleukin 4 expressed in situ selectively alters thymocyte development